Klinefelter's syndrome
Enable an agent to recognise Klinefelter's syndrome, distinguish diagnostic evidence from variable manifestations, and identify appropriate assessment and support needs.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to recognise Klinefelter's syndrome, distinguish diagnostic evidence from variable manifestations, and identify appropriate assessment and support needs.
Klinefelter syndrome is a sex chromosome condition in individuals with a male phenotype, usually associated with a 47,XXY karyotype, that commonly causes impaired testicular function and sperm production, with variable physical, developmental and metabolic features.
It can be Check whether chromosome evidence supports the registered condition and flag uncertain classification boundaries.; Request missing diagnostic provenance or specialist review when screening, phenotype and laboratory evidence disagree.; Summarise endocrine, reproductive and developmental findings in their age and treatment context.; Identify assessment and referral needs using a named, dated clinical guideline.; Track benefits, adverse effects and unmet needs during condition-specific management.; Explain uncertainty and support informed discussion without predicting an individual's abilities or fertility from karyotype alone..
Distinguishing features
Identify the characteristic extra X chromosome in a Y-containing chromosome complement, commonly 47,XXY, including 46,XY/47,XXY mosaicism; distinguish this from 47,XYY. [MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/klinefelter-syndrome/)
Require chromosome evidence for confirmation rather than treating small testes, low testosterone, tall stature or infertility as individually diagnostic. [MedlinePlus Medical Encyclopedia](https://www.medlineplus.gov/ency/article/000382.htm)
Separate prenatal screening suspicion from a confirmed chromosome finding and from assessment of postnatal manifestations.
Do not infer a uniform phenotype from an XXY result: manifestations vary, and a mosaic result describes the tested sample. [MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/klinefelter-syndrome/)
Record the classification authority before including higher-order chromosome variations under this label; terminology differs across references. [NICHD overview](https://www.nichd.nih.gov/health/topics/klinefelter/conditioninfo)
Scope
+ 47,XXY and mosaic 46,XY/47,XXY presentations, with explicit boundaries for other sex-chromosome variations
+ Chromosome-test evidence, ascertainment pathway and diagnostic certainty
+ Age-dependent gonadal, endocrine, reproductive and developmental manifestations
+ Associated health risks, assessed complications and functional support needs
+ Condition-specific management decisions and unresolved evidence
- The person's identity, gender identity and complete health record
- Laboratory procedures and specimen workflows as independently managed processes
- Individual visits, referrals and episodes of care
- Independent models of infertility, osteoporosis, diabetes and other associated conditions
- Other sex-chromosome variations unless explicitly related through a documented classification
Characteristics
- Chromosome complement
- Reported cytogenetic notation; 47,XXY; 46,XY/47,XXY; other explicitly reviewed complement; unknown Anchors recognition and prevents conflation with other chromosome conditions.
- Diagnostic assertion status
- Suspected; screening-positive; confirmed; unresolved; excluded, with date and evidence Prevents screening results and clinical suspicion from becoming confirmed diagnoses.
- Observed mosaicism
- Cell-line counts and proportions, specimen, method and detection limitations Makes the scope of the laboratory observation explicit without extrapolating it to every tissue.
- Life-course context
- Prenatal; childhood; pubertal development; adulthood; later life, with age Determines which manifestations and assessments can be meaningfully interpreted.
- Gonadal endocrine profile
- Testosterone in nmol/L or ng/dL; LH and FSH in IU/L; collection time, reference intervals and treatment context Supports age-appropriate assessment of gonadal function without defining the condition by hormone values alone.
- Reproductive assessment
- Not assessed; assessment deferred; semen findings documented; specialist assessment documented Prevents assuming an individual's fertility status from the syndrome label.
- Developmental and functional profile
- Language, learning, motor and psychosocial findings: assessed result, absent, present or unknown Connects support to demonstrated needs rather than a presumed level of disability.
- Classification mapping
- ICD-10 jurisdiction and edition, ICD-11 release, or SNOMED CT edition and release, with verified identifier Preserves versioned coding without substituting a billing or terminology code for diagnostic evidence.
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 19 findings · 29 questions.
Chromosomal identity Represent the chromosome finding and the boundary of the syndrome label.
Recognition depends on chromosomal evidence, while phenotype and terminology alone can mislead.
Chromosome evidence
Preserve the original laboratory finding and its limits.
Reported complement
Record the exact chromosome notation, specimen, test method, laboratory interpretation and observed cell lines.
- What chromosome complement was reported, by which laboratory, using which specimen and method? provenance
- If mosaicism was investigated, what cell counts, proportions and detection limitations were reported? measurement
Aetiology and boundaries
Separate general chromosomal mechanism from case-specific evidence and classification.
Mechanism and label
Distinguish an established chromosome finding from inferred origin, and preserve the authority defining which complements the label includes.
- What evidence supports the proposed chromosome-segregation mechanism, and what remains unestablished in this case? provenance
- Does the adopted classification include this complement within Klinefelter's syndrome or identify a neighbouring condition? boundary
Diagnosis and ascertainment Track how suspicion becomes a supported diagnostic assertion.
Prenatal screening, clinical presentation, confirmed diagnosis and administrative coding carry different evidential weight.
Diagnostic pathway
Describe the trigger for investigation and resulting certainty.
Confirmation status
Keep screening results and suggestive manifestations distinct from diagnostic confirmation.
- Was investigation prompted by prenatal screening, pubertal development, infertility, developmental concerns or an incidental finding? provenance
- Which diagnostic evidence supports the current assertion, and what confirmation or interpretation remains outstanding? definition
Criteria and populations
Attach authorities and denominators to diagnostic and epidemiological claims.
Versioned interpretation
Record diagnostic guidance, terminology releases and population ascertainment without inventing codes or prevalence estimates.
- Which issuing body, document date and terminology release support the diagnostic definition and code mapping? provenance
- For a frequency estimate, what year, geography, denominator and ascertainment method distinguish chromosome prevalence from diagnosed prevalence? measurement
Gonadal function and reproduction Represent pubertal development, hormone function and individual reproductive evidence.
Endocrine and fertility concerns require related but distinct assessments.
Puberty and endocrine state
Interpret gonadal findings against age, pubertal development and treatment exposure.
Gonadal assessment
Capture pubertal progression, testicular findings, symptoms and hormone results without presuming identical trajectories.
- What pubertal stage, testicular measurements and symptoms were observed, and when? measurement
- How do testosterone, LH and FSH results relate to age-specific reference intervals, sampling time and current hormone treatment? measurement
Fertility evidence and intentions
Separate reproductive wishes, measured function and specialist options.
Individual reproductive status
Record fertility evidence and counselling without equating the syndrome with a guaranteed reproductive outcome.
- What semen or specialist findings establish current reproductive status, and what has not been assessed? measurement
- What reproductive wishes and endocrine-treatment plans require coordinated fertility counselling? action
Development and associated health Represent functional variation and assessed health concerns across life.
A chromosome label does not specify an individual's developmental profile or establish an associated disease.
Learning and participation
Capture demonstrated developmental and psychosocial needs.
Functional support profile
Record language, learning, motor and psychosocial assessments alongside strengths and participation goals.
- Which assessments document strengths or difficulties, and how do these affect education, work or daily life? measurement
- Which speech, educational, psychological or occupational supports match the person's assessed needs and preferences? action
Health risk and disease
Keep population associations distinct from individual findings.
Associated health assessment
Organise guideline-based review of bone, metabolic, vascular and breast health while distinguishing risk, investigation and diagnosed disease.
- Which associated risks warrant assessment under the selected guideline, given age, history and treatment? action
- Which concerns are documented diagnoses, abnormal findings, population-level risks or unassessed possibilities? boundary
Management and life-course review Connect supported interventions to individual objectives and follow-up.
Management addresses manifestations and needs over time; treatment response must be evaluated separately from chromosomal identity.
Intervention decisions
Document the reason, evidence and consent for condition-specific management.
Individualised management
Record the indication and intended outcome for hormone treatment, fertility referral or developmental support. [NICHD treatment overview](https://www.nichd.nih.gov/health/topics/klinefelter/conditioninfo/treatments)
- Which measured finding or expressed need supports the proposed intervention, and which dated guideline supports it? action
- What benefits, uncertainties, reproductive implications and consent or assent requirements were discussed? provenance
Longitudinal review
Track changing manifestations, intervention outcomes and continuity of care.
Response and transition
Preserve baseline findings, follow-up outcomes and responsibility for review across paediatric and adult services.
- What changes in symptoms, laboratory results, function or adverse effects occurred relative to baseline? measurement
- Who owns the next review, and which unresolved endocrine, fertility or support needs must transfer between services? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- This is recalled knowledge, not a researched or source-verified account.
- Check current guideline editions, ICD revisions and terminology boundaries before publication, especially for higher sex chromosome aneuploidies.
- Prevalence and hormone reference ranges are omitted because they require population, age, assay and ascertainment context; the condition is distinct from its diagnosis or an episode of care.
- Which of these check these first hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Non-mosaic 47,XXY Klinefelter syndrome
- Mosaic Klinefelter syndrome, commonly 46,XY/47,XXY
- Which of these kinds and varieties hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- ISCN cytogenetic nomenclature - 47,XXY - The usual non-mosaic karyotype; mosaic results specify each cell line and the number of cells examined.
- WHO ICD-10 - Q98.0 - Klinefelter syndrome with karyotype 47,XXY; other cytogenetic configurations require checking the applicable category and national revision.
- Which of these identifiers and schemes hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Standards and regulation
Recalled without web access and unsourced; every item is a lead to verify.
- World Health Organization ICD-10 classifies the condition for diagnostic coding; classification codes do not themselves establish the diagnosis.
- European Academy of Andrology clinical guidelines address diagnosis and management of Klinefelter syndrome.
- Which of these standards and regulation hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Cytogenetic investigation of suspected sex chromosome variation, including during infertility assessment.
- Assessment and management of testicular hormone deficiency.
- Fertility counselling and evaluation for assisted reproduction.
- Individual assessment of speech, language, learning and psychosocial support needs.
- Monitoring of bone health and metabolic risk.
- Which of these real-world use hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Chromosome count in the usual non-mosaic karyotype - 47, including two X chromosomes and one Y chromosome - chromosomes per nucleated somatic cell
- Which of these typical measurements hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Variable or subtle features can lead to delayed or missed diagnosis.
- Impaired sperm production frequently causes infertility, but infertility is not absolute in every individual.
- Testicular hormone deficiency can contribute to reduced bone density and other health effects.
- Elevated risks include metabolic disorders and venous thromboembolism.
- Assuming a uniform intellectual, behavioural or physical profile can produce inappropriate care and stigma.
- Which of these failure modes and hazards hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- National ICD adaptations and coding revisions can differ.
- Access to cytogenetic diagnosis, endocrine care, fertility services and developmental support varies between health systems.
- Which of these regional variation hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- 47,XYY syndrome - The additional sex chromosome is Y rather than X.
- 46,XX testicular difference of sex development - Testicular development occurs with a 46,XX karyotype rather than the usual 47,XXY configuration.
- 48,XXYY and 48,XXXY syndromes - These have additional sex chromosome copies and distinguishable clinical profiles; they should not automatically be treated as interchangeable Klinefelter variants.
- Male hypogonadism - This is a broader functional diagnosis with multiple causes; it does not establish an XXY chromosome constitution.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of Klinefelter's syndrome this model covers, and on what evidence? provenance
What the second pass must settle
- Does an existing Vercy world model already own this concept, requiring a registry link instead of a separate publication?
- Which classification authority should govern whether higher-order or unusual mosaic chromosome complements belong here or in neighbouring models?
- What are the verified ICD-10 jurisdiction-specific, ICD-11 and SNOMED CT mappings and release dates for the adopted scope?
- Which current specialist guidelines should govern age-specific endocrine assessment, fertility counselling and surveillance intervals?
- Which population studies provide defensible birth-prevalence and diagnosed-prevalence estimates, with explicit denominators, years and ascertainment limitations?